SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Benchmark Initiates Coverage On Bio-Techne with Buy Rating, Announces Price Target of $320

Benchmark analyst Robert Wasserman initiates coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and announces Price Target of $320.

Benzinga · 05/14/2020 12:05

Benchmark analyst Robert Wasserman initiates coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and announces Price Target of $320.